Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro

Journal of Hepatology

Volumn 29, Issue 4, 1998, Pages 550-558

  Cruickshank, Sheena M ^a   Southgate, Jennifer ^a   Selby, Peter J ^a   Trejdosiewicz, Ludwik K ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Biliary; CD40; CD44; CD95; Cytokines; Epithelia; Immunoregulation

Indexed keywords

ALPHA INTERFERON; CD40 ANTIGEN; CELL SURFACE MARKER; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FAS ANTIGEN; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; BILIARY CIRRHOSIS; CELL CULTURE; CELL SURFACE; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0032192339     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80149-9     Document Type: Article

References (55)

1. + T cells. Hepatology 1996; 24: 561-7.
2. 2. Ayres RC, Neuberger JM, Shaw J, Joplin R, Adams DH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines. Gut 1993; 34: 1245-9.
3. 3. Adams DH, Hubscher SG, Shaw J, Johnson GD, Babbs C, Rothlein R, et al. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991; 14: 426-31.
4. 4. Adams DH, Hubscher SG, Shaw J, Rothlein R, Neuberger JM. Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet 1989; ii: 1122-5.
5. 5. Leon M, Kirby J, Gibbs P, Burt A, Bassendine M. Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules. J Hepatol 1995; 22: 591-6.
6. 6. Spengler U, Leifeld L, Braunschweiger I, Dumoulin FL, Lechmann M, Sauerbruch T. Anomalous expression of co-stimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis. J Hepatol 1997; 26: 31-6.
7. 7. Satoh S, Nussler A, Liu Z, Thomson A. Proinflammatory cytokines and endotoxin stimulate ICAM-1 gene expression and secretion by normal hepatocytes. Immunology 1994; 82: 571-6.
8. 8. Malizia G, Dino O, Pisa R, Caltagirone M, Giannuoli G, Di Marco V, et al. Expression of leukocyte adhesion molecules in the liver of patients with chronic hepatitis B virus infection. Gastroenterology 1991; 100: 749-50.
9. 9. Shinde S, Wu Y, Guo Y, Niu QT, Xu JC, Grewal IS, et al. CD40L is important for induction of, but not response to, costimulatory activity - ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L. J Immunol 1996; 157: 2764-8.
10. 10. Guo Y, Wu Y, Shinde S, Sy MS, Aruffo A, Liu Y. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H. J Exp Med 1996; 184: 955-61.
11. 11. Karmann K, Hughes CC, Fanslow WC, Pober J. Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-1 signaling pathway. Eur J Immunol 1996; 26: 610-7.
12. 12. Gordon J. Cd40 and its ligand: central players in b lymphocyte survival, growth, and differentiation. Blood Rev 1995; 9: 53-6.
13. 13. Klaus SJ, Berberich I, Shu G, Clark EA. Cd40 and its ligand in the regulation of humoral immunity. Semin Immunol 1994; 6: 279-86.
14. 14. Grewal IS, Flavell RA. The CD40 ligand. At the center of the immune universe? Immunol Res 1997; 16: 59-70.
15. 15. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994; 15: 406-11.
16. 16. Shu U, Kiniwa M, Wu C, Maliszewski C, Vezzio N, Hakami J, et al. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 1995; 25: 1125-8.
17. 17. Stüber E, Strober W, Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 1996; 183: 693-8.
18. 18. Stout RD, Suttles J. The many-roles of CD40 in cell-mediated inflammatory responses. Immunol Today 1996; 17: 487-92.
19. 19. Denfeld RW, Hollenbaugh D, Fehrenbach A, Weiss JM, Von Leoprechting A, Mai B, et al. CD40 is functionally expressed on human keratinocytes. Eur J Immunol 1996; 26: 2329-34.
20. 20. Péguet-Navarro J, Dalbiez-Gauthier C, Moulon C, Berthier O, Réano A, Gaucherand M, et al. CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. J Immunol 1997; 158: 144-52.
21. 21. Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM. Elevations in IFNγ, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30. Clin Immunol Immunopathol 1996; 80: 311-20.
22. 22. Vreden SG, van den Broek MF, Oettinger MC, Verhave JP, Meuwissen JH, Sauerwein RW. Cytokines inhibit the development of liver schizonts of the malaria parasite Plasmodium berghei in vivo. Eur J Immunol 1992; 22: 2271-5.
23. 23. O'Donohue J, Williams R. Immunological control in primary biliary cirrhosis: the cytokine story. Clin Exp Immunol 1996; 105: 199-201.
24. 24. Hayashi M, Martinez OM, Garcia-Kennedy R, So S, Esquivel CO, Krams SM. Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation 1995; 60: 1533-8.
25. 25. Pied S, Civas A, Berlot-Picard F, Renia L, Miltgen F, Gentilini M, et al. IL-6 induced by IL-1 inhibits malaria pre-erythrocytic stages but its secretion is down-regulated by the parasite. J Immunol 1992; 148: 197-201.
26. 26. Bromberg JF, Horvath CM, Wen ZL, Schreiber RD, Darnell JE, Jr. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon α and interferon γ. Proc Natl Acad Sci USA 1996; 93: 7673-8.
27. 27. Iacopino F, Ferrandina G, Scambia G, Benedetti-Panic P, Mancuso S, Sica G. Interferons inhibit EGF-stimulated cell growth and reduce EGF binding in human breast cancer cells. Anticancer Res 1996; 16: 1919-24.
28. 28. Mickelson J, Kukielka G, Bravenec J, Mainolfi E, Rothlein R, Hawkins H, et al. Differential expression and release of CD54 induced by cytokines. Hepatology 1995; 22: 866-75.
29. 29. Satoh S, Thomson A, Nakamura K, Warty V, Todo S. Circulating ICAM-1, E-selectin, IL-2 receptor, and HLA class I in human small bowel, liver and small bowel-plus-liver transplant recipients. Transplantation 1995; 60: 558-62.
30. 30. Kvale D, Brandtzaeg P. Immune modulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human hepatocytic cell lines. J Hepatol 1993; 17: 347-52.
31. 31. Dustin M, Ruthlein R, Bhan A, Dinarello C, Springer T. Induction by IL-1 and interferon gamma: tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-54.
32. 32. Jones A, Selby P, Viner C, Hobbs S, Gore M, McElwain T. Tumour necrosis factor, cholestatic jaundice, and chronic liver disease. Gut 1990; 31: 938-9.
33. 33. Cianciara J, Laskus T. Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B. Dig Dis Sci 1995; 40: 1842-4.
34. 34. D'Amico E, Paroli M, Fratelli V, Palazzi C, Barnaba V, Callea F, et al. Primary biliary cirrhosis induced by interferon-α therapy for hepatitis C virus infection. Dig Dis Sci 1995; 40: 2113-6.
35. 35. Chedin P, Cahen-Varsaux J, Boyer N. Non-insulin-dependent diabetes mellitus developing during interferon-α therapy for chronic hepatitis C. Ann Intern Med 1996; 125: 521.
36. 36. Bedossa P, Paradis V. Transforming growth factor-β (TGF-β): a key role in liver fibrogenesis. J Hepatol 1995; 22: 37-42.
37. 37. Southgate J, Hutton KA, Thomas DF, Trejdosiewicz LK. Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest 1994; 71: 583-94.
38. 38. Joplin R, Strain AJ, Neuberger JM. Immuno-isolation and culture of biliary epithelial cells from normal human liver. In Vitro Cell Dev Biol 1989; 25: 1189-92.
39. 39. Momburg F, Moldenhauer G, Hammerling GJ, Moller P. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 1987; 47: 2883-91.
40. 40. Shimizu Y, Demetris AJ, Gollin SM, Storto PD, Bedford HM, Altarac S, et al. Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells. Int J Cancer 1992; 52: 252-60.
41. 41. Southgate J, Trejdosiewicz LK. Immunolabelling of cells and tissues: approaches and pitfalls. Hum Reprod 1997; 12: 66-75.
42. 42. Southgate J, Kennedy W, Hutton K, A, Trejdosiewicz LK. Expression and in vitro regulation of integrins by normal human urothelial cells. Cell Adhes Commun 1995; 3: 231-42.
43. 43. Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro. Science 1994; 264: 1587-9.
44. 44. Sempowski GD, Chess PR, Phipps RP. CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts. J Immunol 1997; 158: 4670-7.
45. 45. Gollob JA, Li H, Reinherz EL, Ritz J. CD2 regulates responsiveness of activated T cells to interleukin 12. J Exp Med 1995; 182: 721-31.
46. 46. Gollob JA, Li J, Kawasaki H, Daley JF, Groves C, Reinherz EL, et al. Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12. J Immunol 1996; 157: 1886-93.
47. 47. Essani N, Fisher M, Farhood A, Manning A, Smith C, Jaeschke H. Cytokine-induced upregulation of hepatic intercellular adhesion molecule-1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. Hepatology 1995; 21: 1632-9.
48. 48. Leon MP, Bassendine MF, Gibbs P, Thick M, Kirby JA. Immunogenicity of biliary epithelium: study of the adhesive interaction with lymphocytes. Gastroenterology 1997; 112: 968-77.
49. 49. Chakrabarti D, Hultgren B, Stewart T. IFN-α induces autoimmune T cells through the induction of Intracellular Adhesion Molecule-1 and B7.2. J Immunol 1996; 157: 522-8.
50. 50. Harada K, Van de Water J, Leung PSC, Coppel RL, Ansari A, Nakanuma Y, et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 1997; 25: 791-6.
51. 51. Shindo M, Mullin GE, Braun-Elwert L, Bergasa NV, Jones EA, James SP. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clin Exp Immunol 1996; 105: 254-9.
52. 52. Schattner E, Friedman SM. Fas expression and apoptosis in human B cells. Immunol Res 1996; 15: 246-57.
53. 53. Rouquet N, Carlier K, Briand P, Wiels J, Joulin V. Multiple pathways of Fas-induced apoptosis in primary culture of hepatocytes. Biochem Biophys Res Commun 1996; 229:27-35.
54. 54. Tanaka Y, Adams D, Hubscher S, Hirano H, Siebenlist U, Shaw S. T cell adhesion induced by proteoglycan-immobilised cytokine MIP-1b. Nature 1993; 361: 79-82.
55. 55. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, et al. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 1995; 128: 687-98.